Kennametal Q4 Earnings & Sales Beat Estimates, Rise Y/Y

Kennametal (KMT) reported Q4 fiscal 2026 adjusted EPS of $2.96, up 770.6% YoY, beating the $2.31 consensus by 28.1%, as revenue jumped 42.7% YoY to $736.6M (vs. $720M consensus). Profitability surged with adjusted operating margin expanding to 41.5% (from 7.4%) and adjusted EBITDA margin to 46.8% (from 14.8%), helped by ~$252M favorable raw-material pricing/cost timing. Despite this, operating cash flow fell to $4.0M (from $208.3M) and free operating cash flow was -$79.1M due to working-capital strain; management expects FQ1 sales of $745-$775M and adjusted EPS of $2.50-$2.80, and FY2027 adjusted EPS of $4.15-$5.15 with buybacks on hold until cash flow turns positive.

Analysis

The market is likely to misread this as a clean earnings-quality breakout when it is closer to a working-capital timing event with deferred cash pain. The equity can re-rate on headline EPS in the very near term, but the combination of negative operating cash flow, inventory build, and suspended buybacks means the durability of the margin step-up is the real question; once the pricing/cost timing benefit normalizes, the earnings power implied by the quarter is likely overstated.

Relative winners are higher-quality industrial compounders such as AIT and IEX, which should screen better as investors rotate toward balance-sheet discipline and conversion of revenue into cash rather than accounting margin. KMT’s cash strain also creates a subtle competitive risk: if it leans harder on price and tariff surcharges to defend margins, it may lose share in lower-friction channels to distributors and engineered-products peers with cleaner service levels and less inventory distortion.

The key catalyst window is 1-3 months, when the next quarter should reveal whether inventory unwinds and free cash flow turns positive; the structural 6-18 month risk is that the company is forced to prioritize deleveraging over capital returns, capping the multiple. Contrarian view: consensus may be too focused on the earnings beat and not enough on the fact that the margin expansion is not fully cash-backed. What would falsify the bearish thesis is a rapid decline in inventories, positive operating cash flow by the next report, and explicit resumption of repurchases; absent that, this looks like a candidate for multiple compression rather than sustained rerating.

Key Decisions for Investors

• Short KMT on post-earnings strength for a 1-3 month horizon; target underperformance is driven by cash conversion skepticism, with risk defined by a faster-than-expected inventory unwind and positive FCF inflection.
• Pair trade: long AIT / short KMT, 3-6 months. AIT’s cleaner cash generation and steadier earnings quality should attract a premium as industrial investors move away from timing-driven margin stories.
• Pair trade: long IEX / short KMT, 3-6 months. IEX has better capital-allocation optics and less exposure to the 'headline EPS, weak cash flow' penalty that can compress KMT’s multiple.
• Buy KMT put spreads 2-4 months out only on any gap-up reaction; this is a tactical fade of a likely overbought move, with the thesis invalidated if the company shows clear working-capital release in the next quarter.